Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamantis I Tsilimigras

Showing results (1-10 of 386) with videos related to

Pageof 39
Sort By:
The New England Journal of Medicine|May 7, 2025
Cabozantinib in Advanced Neuroendocrine TumorsDiamantis I Tsilimigras
Annals of Surgical Oncology|May 21, 2021
ASO Author Reflections: Minority-Serving Hospitals are Associated with Lower Likelihood of Providing NCCN Guideline Compliant Care to Patients with Resectable CholangiocarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Surgery|November 23, 2024
Response to letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma"Diamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|May 28, 2024
ASO Author Reflections: Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career StagesDiamantis I Tsilimigras, Timothy M Pawlik
The British Journal of Surgery|September 21, 2020
Tumour Burden Score: An Authentic, Easy-To-Use Prognostic Marker for Hepatocellular CarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|January 4, 2024
ASO Author Reflections: Perioperative Lymphopenia Following Hepatectomy for Hepatocellular Carcinoma: A Routine Yet Overlooked Prognostic BiomarkerDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Translational Medicine|January 13, 2021
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma: AcknowledgmentsDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|February 22, 2024
ASO Author Reflections: Early-Onset Intrahepatic Cholangiocarcinoma-Poor Oncological Outcomes and Distinct Molecular FeaturesDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|April 11, 2024
ASO Author Reflections: ICC PRS Score: Clinically Useful Tool to Predict Post-recurrence Survival and Guide Management of Recurrent Intrahepatic CholangiocarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|August 19, 2025
ASO Author Reflections: Isolated Mesoappendiceal Invasion Is Not an Indication for Right Hemicolectomy in Appendiceal Neuroendocrine TumorsDiamantis I Tsilimigras, Jordan M Cloyd
Pageof 39

Showing results (1-10 of 386) with videos related to

Sort By:
Pageof 39
The New England Journal of Medicine|May 7, 2025
Cabozantinib in Advanced Neuroendocrine TumorsDiamantis I Tsilimigras
Annals of Surgical Oncology|May 21, 2021
ASO Author Reflections: Minority-Serving Hospitals are Associated with Lower Likelihood of Providing NCCN Guideline Compliant Care to Patients with Resectable CholangiocarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Surgery|November 23, 2024
Response to letter to the editor on "Long-term lorazepam use may be associated with worse long-term outcomes among patients with pancreatic adenocarcinoma"Diamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|May 28, 2024
ASO Author Reflections: Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career StagesDiamantis I Tsilimigras, Timothy M Pawlik
The British Journal of Surgery|September 21, 2020
Tumour Burden Score: An Authentic, Easy-To-Use Prognostic Marker for Hepatocellular CarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|January 4, 2024
ASO Author Reflections: Perioperative Lymphopenia Following Hepatectomy for Hepatocellular Carcinoma: A Routine Yet Overlooked Prognostic BiomarkerDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Translational Medicine|January 13, 2021
Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma: AcknowledgmentsDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|February 22, 2024
ASO Author Reflections: Early-Onset Intrahepatic Cholangiocarcinoma-Poor Oncological Outcomes and Distinct Molecular FeaturesDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|April 11, 2024
ASO Author Reflections: ICC PRS Score: Clinically Useful Tool to Predict Post-recurrence Survival and Guide Management of Recurrent Intrahepatic CholangiocarcinomaDiamantis I Tsilimigras, Timothy M Pawlik
Annals of Surgical Oncology|August 19, 2025
ASO Author Reflections: Isolated Mesoappendiceal Invasion Is Not an Indication for Right Hemicolectomy in Appendiceal Neuroendocrine TumorsDiamantis I Tsilimigras, Jordan M Cloyd
Pageof 39